0001822629-24-000008.txt : 20240325
0001822629-24-000008.hdr.sgml : 20240325
20240325160950
ACCESSION NUMBER: 0001822629-24-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240323
FILED AS OF DATE: 20240325
DATE AS OF CHANGE: 20240325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lalwani Nikhil
CENTRAL INDEX KEY: 0001822629
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 24779307
MAIL ADDRESS:
STREET 1: C/O ANI PHARMACEUTICALS, INC.
STREET 2: 210 MAIN STREET
CITY: BAUDETTE
STATE: MN
ZIP: 56623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
wk-form4_1711397380.xml
FORM 4
X0508
4
2024-03-23
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001822629
Lalwani Nikhil
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
1
1
0
0
PRESIDENT & CEO
0
Common Stock
2024-03-23
4
F
0
17455
69.58
D
394174
D
Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported.
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
2024-03-25